Claire Bird

Litmas Pty Ltd

Dr Bird is a committed and driven Scientist and business owner delivering healthier buildings through a research, commercial and academic laboratory management, training, and consulting background. Claire completed a Doctoral degree in Bioaerosol detection and characterisation in 2004 before moving to Australia to establish the Environmental Biotechnology laboratory at Flinders University. Today, she is dedicated to delivery of established and cutting-edge microbial analytical products, processes and services through her Australian based laboratory, LITMAS. Claire has operated and managed some of Australia’s largest building contamination projects, uniquely positioning her at the junction of scientific research and real-world application. Claire is involved in ongoing research and development in the area of indoor air quality and the indoor microbiome. She is participating in the Macquarie University NHMRC research project into biotoxin-related illness with scientists, engineers, patients and clinicians, as well as supporting devel0pment through newly announced Queensland University of Technology IAQ School. She is frequently asked for written and verbal presentation on the topic of indoor air quality and disease transmission.

Claire loves connecting people who can support each other’s work, and strongly advocates for better Indoor Air Quality, volunteering extensively as a subject matter expert and liaison point across a speciality and geographically diverse range of indoor air quality (IAQ) associated National and International professional bodies and organisations.

Former elected inaugural President of the Indoor Air Quality Association Australia and Chapter Director of the global Indoor Air Quality Association, Claire now operates as Executive Director of the global-based Integrated Biosciences and Built Environment Consortium (IBEC) who coordinates a team of world leading scientific advisers around pathogens, people, and buildings. Through this work she has been heavily involved in the roll out of the CDC-funded Commit 2 CARE program developed with the American Industrial Hygiene Association and supported by AIOH, as an easily accessible platform for self-assessment of how best to mitigate infection spread for individuals and businesses.